Alcohol Consumption Increases Risk Of Lobular And HR+ Breast Cancer
Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer
Brothers Of Prostate Cancer Patients At Risk Of Diagnosis
Estrogen Alone Didn’t Increase Lung Cancer Mortality In WHI
Tumors Harder To Detect In Women In Their Forties
Two Avastin Trials Show OS Benefit In Advanced Disease
Risk-Benefit Analysis Advised Prior To Hormone Therapy
Elderly Patients Fail To Receive New Cancer Therapy For CML
Rising Obesity May Result In Higher Cancer Incidence
Study Finds Relationship Between Meat Intake, Cancer
Radiation To Stem Cell Niche Improved PFS In Glioblastoma
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy
- Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure - Alec Kimmelman announced as next CEO and Dean of NYU Langone Health
